表紙
市場調查報告書

淋巴瘤治療藥的全球市場

Lymphoma Therapeutics

出版商 Global Industry Analysts, Inc. 商品編碼 912749
出版日期 內容資訊 英文 142 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
淋巴瘤治療藥的全球市場 Lymphoma Therapeutics
出版日期: 2019年10月01日內容資訊: 英文 142 Pages
簡介

本報告提供全球淋巴瘤治療藥市場概要,彙整趨勢·發展的影響因素分析,競爭企業與市場佔有率,世界及地區·各主要國家的市場規模的變化與預測,主要企業簡介等資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球淋巴瘤治療藥市場上企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美國家
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東
    • 非洲

第4章 競爭企業

  • AMGEN
  • CELGENE CORPORATION
  • F. HOFFMANN-LA ROCHE AG
  • JOHNSON & JOHNSON
  • SEATTLE GENETICS
  • Astellas Pharma Inc.
  • ASTRAZENECA PLC
  • BRISTOL-MYERS SQUIBB COMPANY
  • 中外製藥
  • Eisai
  • ELI LILLY AND COMPANY
  • FORMA THERAPEUTICS
  • GLAXOSMITHKLINE PLC
  • IMMUNOMEDICS
  • MERCK & CO., INC.
  • PFIZER, INC
  • SPECTRUM PHARMACEUTICALS
  • TRANSGENE SA

第5章 調查資料

目錄
Product Code: MCP-6298

Lymphoma Therapeutics market worldwide is projected to grow by US$9.3 Billion, driven by a compounded growth of 7.7%. Hodgkin Lymphoma (HL), one of the segments analyzed and sized in this study, displays the potential to grow at over 7%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$2.2 Billion by the year 2025, Hodgkin Lymphoma (HL) will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 6.5% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$323.7 Million to the region's size and clout in the next 5 to 6 years. Over US$278.5 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Hodgkin Lymphoma (HL) will reach a market size of US$139.3 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 11.4% over the next couple of years and add approximately US$2.6 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Celgene Corporation; F. Hoffmann-La Roche AG; Johnson & Johnson; Seattle Genetics, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Lymphoma Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Lymphoma Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Lymphoma Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Lymphoma Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Hodgkin Lymphoma (HL) (Disease Type) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Hodgkin Lymphoma (HL) (Disease Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Hodgkin Lymphoma (HL) (Disease Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Non-Hodgkin Lymphoma (NHL) (Disease Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Non-Hodgkin Lymphoma (NHL) (Disease Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Non-Hodgkin Lymphoma (NHL) (Disease Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Lymphoma Therapeutics Market Share (in %) by Company: 2019 & 2025
    • TABLE 10: United States Lymphoma Therapeutics Market Estimates and Projections in US$ Million by Disease Type: 2018 to 2025
    • TABLE 11: Lymphoma Therapeutics Market in the United States by Disease Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 12: United States Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 13: Canadian Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Disease Type: 2018 to 2025
    • TABLE 14: Canadian Lymphoma Therapeutics Historic Market Review by Disease Type in US$ Million: 2009-2017
    • TABLE 15: Lymphoma Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025
  • JAPAN
    • TABLE 16: Japanese Market for Lymphoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Disease Type for the Period 2018-2025
    • TABLE 17: Lymphoma Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Disease Type for the Period 2009-2017
    • TABLE 18: Japanese Lymphoma Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 19: Chinese Lymphoma Therapeutics Market Growth Prospects in US$ Million by Disease Type for the Period 2018-2025
    • TABLE 20: Lymphoma Therapeutics Historic Market Analysis in China in US$ Million by Disease Type: 2009-2017
    • TABLE 21: Chinese Lymphoma Therapeutics Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Lymphoma Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 22: European Lymphoma Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 23: Lymphoma Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 24: European Lymphoma Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 25: European Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Disease Type: 2018-2025
    • TABLE 26: Lymphoma Therapeutics Market in Europe in US$ Million by Disease Type: A Historic Review for the Period 2009-2017
    • TABLE 27: European Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 28: Lymphoma Therapeutics Market in France by Disease Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 29: French Lymphoma Therapeutics Historic Market Scenario in US$ Million by Disease Type: 2009-2017
    • TABLE 30: French Lymphoma Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 31: Lymphoma Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2018-2025
    • TABLE 32: German Lymphoma Therapeutics Historic Market Analysis in US$ Million by Disease Type: 2009-2017
    • TABLE 33: German Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 34: Italian Lymphoma Therapeutics Market Growth Prospects in US$ Million by Disease Type for the Period 2018-2025
    • TABLE 35: Lymphoma Therapeutics Historic Market Analysis in Italy in US$ Million by Disease Type: 2009-2017
    • TABLE 36: Italian Lymphoma Therapeutics Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 37: United Kingdom Market for Lymphoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Disease Type for the Period 2018-2025
    • TABLE 38: Lymphoma Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Disease Type for the Period 2009-2017
    • TABLE 39: United Kingdom Lymphoma Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 40: Spanish Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Disease Type: 2018 to 2025
    • TABLE 41: Spanish Lymphoma Therapeutics Historic Market Review by Disease Type in US$ Million: 2009-2017
    • TABLE 42: Lymphoma Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 43: Russian Lymphoma Therapeutics Market Estimates and Projections in US$ Million by Disease Type: 2018 to 2025
    • TABLE 44: Lymphoma Therapeutics Market in Russia by Disease Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 45: Russian Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 46: Rest of Europe Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Disease Type: 2018-2025
    • TABLE 47: Lymphoma Therapeutics Market in Rest of Europe in US$ Million by Disease Type: A Historic Review for the Period 2009-2017
    • TABLE 48: Rest of Europe Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 49: Asia-Pacific Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 50: Lymphoma Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 51: Asia-Pacific Lymphoma Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 52: Lymphoma Therapeutics Market in Asia-Pacific by Disease Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 53: Asia-Pacific Lymphoma Therapeutics Historic Market Scenario in US$ Million by Disease Type: 2009-2017
    • TABLE 54: Asia-Pacific Lymphoma Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 55: Lymphoma Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2018-2025
    • TABLE 56: Australian Lymphoma Therapeutics Historic Market Analysis in US$ Million by Disease Type: 2009-2017
    • TABLE 57: Australian Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 58: Indian Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Disease Type: 2018 to 2025
    • TABLE 59: Indian Lymphoma Therapeutics Historic Market Review by Disease Type in US$ Million: 2009-2017
    • TABLE 60: Lymphoma Therapeutics Market in India: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 61: Lymphoma Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2018-2025
    • TABLE 62: South Korean Lymphoma Therapeutics Historic Market Analysis in US$ Million by Disease Type: 2009-2017
    • TABLE 63: Lymphoma Therapeutics Market Share Distribution in South Korea by Disease Type: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 64: Rest of Asia-Pacific Market for Lymphoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Disease Type for the Period 2018-2025
    • TABLE 65: Lymphoma Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Disease Type for the Period 2009-2017
    • TABLE 66: Rest of Asia-Pacific Lymphoma Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 67: Latin American Lymphoma Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 68: Lymphoma Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 69: Latin American Lymphoma Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 70: Latin American Lymphoma Therapeutics Market Growth Prospects in US$ Million by Disease Type for the Period 2018-2025
    • TABLE 71: Lymphoma Therapeutics Historic Market Analysis in Latin America in US$ Million by Disease Type: 2009-2017
    • TABLE 72: Latin American Lymphoma Therapeutics Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 73: Argentinean Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Disease Type: 2018-2025
    • TABLE 74: Lymphoma Therapeutics Market in Argentina in US$ Million by Disease Type: A Historic Review for the Period 2009-2017
    • TABLE 75: Argentinean Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 76: Lymphoma Therapeutics Market in Brazil by Disease Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 77: Brazilian Lymphoma Therapeutics Historic Market Scenario in US$ Million by Disease Type: 2009-2017
    • TABLE 78: Brazilian Lymphoma Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 79: Lymphoma Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2018-2025
    • TABLE 80: Mexican Lymphoma Therapeutics Historic Market Analysis in US$ Million by Disease Type: 2009-2017
    • TABLE 81: Mexican Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 82: Rest of Latin America Lymphoma Therapeutics Market Estimates and Projections in US$ Million by Disease Type: 2018 to 2025
    • TABLE 83: Lymphoma Therapeutics Market in Rest of Latin America by Disease Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 84: Rest of Latin America Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 85: The Middle East Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 86: Lymphoma Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 87: The Middle East Lymphoma Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 88: The Middle East Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Disease Type: 2018 to 2025
    • TABLE 89: The Middle East Lymphoma Therapeutics Historic Market by Disease Type in US$ Million: 2009-2017
    • TABLE 90: Lymphoma Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025
  • IRAN
    • TABLE 91: Iranian Market for Lymphoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Disease Type for the Period 2018-2025
    • TABLE 92: Lymphoma Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Disease Type for the Period 2009-2017
    • TABLE 93: Iranian Lymphoma Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 94: Israeli Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Disease Type: 2018-2025
    • TABLE 95: Lymphoma Therapeutics Market in Israel in US$ Million by Disease Type: A Historic Review for the Period 2009-2017
    • TABLE 96: Israeli Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 97: Saudi Arabian Lymphoma Therapeutics Market Growth Prospects in US$ Million by Disease Type for the Period 2018-2025
    • TABLE 98: Lymphoma Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Disease Type: 2009-2017
    • TABLE 99: Saudi Arabian Lymphoma Therapeutics Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 100: Lymphoma Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2018-2025
    • TABLE 101: United Arab Emirates Lymphoma Therapeutics Historic Market Analysis in US$ Million by Disease Type: 2009-2017
    • TABLE 102: Lymphoma Therapeutics Market Share Distribution in United Arab Emirates by Disease Type: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 103: Lymphoma Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2018-2025
    • TABLE 104: Rest of Middle East Lymphoma Therapeutics Historic Market Analysis in US$ Million by Disease Type: 2009-2017
    • TABLE 105: Rest of Middle East Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 106: African Lymphoma Therapeutics Market Estimates and Projections in US$ Million by Disease Type: 2018 to 2025
    • TABLE 107: Lymphoma Therapeutics Market in Africa by Disease Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 108: African Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

IV. COMPETITION

  • AMGEN
  • CELGENE CORPORATION
  • F. HOFFMANN-LA ROCHE AG
  • JOHNSON & JOHNSON
  • SEATTLE GENETICS
  • ASTELLAS PHARMA, INC.
  • ASTRAZENECA PLC
  • BRISTOL-MYERS SQUIBB COMPANY
  • CHUGAI PHARMACEUTICAL
  • EISAI CO.
  • ELI LILLY AND COMPANY
  • FORMA THERAPEUTICS
  • GLAXOSMITHKLINE PLC
  • IMMUNOMEDICS
  • MERCK & CO., INC.
  • PFIZER, INC
  • SPECTRUM PHARMACEUTICALS
  • TRANSGENE SA

V. CURATED RESEARCH

Back to Top